Laddar...

In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology

FDA approval of anti-CTLA4 in 2011 for melanoma immunotherapy was paradigm shifting and dramatically accelerated cancer immunotherapy research. The investment and effort have been exceptionally large, with a commensurate impressive pace of discovery. Historical and current research has validated the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Hyperthermia
Huvudupphovsmän: Mao, Chenkai, Gorbet, Michael-Joseph, Singh, Akansha, Ranjan, Ashish, Fiering, Steven
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2020
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189648/
https://ncbi.nlm.nih.gov/pubmed/33455477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/02656736.2020.1810333
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!